febuxostat Oral Tablet [Uloric]

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Febuxostat (Adenuric®, Uloric®, Feburic®) is an orally-active, potent, non-purine, selective xanthine oxidase inhibitor. In the… Expand
  • table 1
  • table 2
  • table 3
  • figure 2
  • table 4
Is this relevant?
2014
2014
Sources of nitric oxide alternative to nitric oxide synthases are gaining significant traction as crucial mediators of vessel… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2009
2009
  • ULORIC febuxostat
  • 2009
------------------------DOSAGE AND ADMINISTRATION---------------------• ULORIC is recommended at 40 mg or 80 mg once daily. The… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?